Summary
Procyclidine (up to 20mg/kg i.p.) did not influence the electroconvulsive threshold per se, but when given in a dose of 10mg/kg, it potentiated the protective activity of carbamazepine, diphenylhydantoin, phenobarbital and valproate, and in a dose of 20 mg/kg, that of diazepam against maximal electroshock-induced convulsions in mice. Ifenprodil increased the threshold for electroconvulsions when applied at 20 and 40 mg/kg (i.p.), but surprisingly, when combined with all antiepileptics tested, it did not influence their anticonvulsant actions. The chimney test in mice revealed, that application of procyclidine at 10 mg/kg together with phenobarbital and valproate, and procyclidine at 20 mg/kg with diazepam resulted in motor impairment. However, when procyclidine was applied at 10 mg/kg together with carbamazepine or diphenylhydantoin, no motor impairment was noted. The combined treatment of procyclidine (10 mg/kg) with carbamazepine, diphenylhydantoin, phenobarbital or valproate, as well as procyclidine (20 mg/kg) with diazepam caused significant worsening of long-term memory. Finally, procyclidine did not alter the total plasma levels of carbamazepine, diazepam, diphenylhydantoin, phenobarbital and valproate.
It may be concluded that not all agents interfering with NMDA receptor complex-mediated events lead to the potentiation of the anticonvulsant activity of antiepileptic drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albright PS, Burnham WM, Okazaki M (1979) Effect of atropine sulfate on amygdaloid kindling in the rat. Exp Neurol 66: 409–412
Bianchine JR (1985) Drugs for Parkinson's disease, spasticity, and acute muscle spasms. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 473–490
Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle methode simple pour explorer l'action ‘tranquilisante’: le test de la cheminee. Med Exp (Basel) 3: 81–84
Carter C, Rivy JP, Scatton B (1989) Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor. Eur J Pharmacol 164: 611–612
Czechowska G, Dziki M, Pietrasiewicz T, Kleinrok Z, Turski WA, Czuczwar SJ (1993) Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551 enhance the anticonvulsant activity of valproate against electroconvulsions in mice. Eur J Pharmacol 232: 59–64
Czuczwar SJ, Turski L, Chmielewska B, Turski WA, Kleinrok Z (1985) Modification of the anticonvulsant activity of 2-amino-5-phosphonovalerate by agents affecting different neurotransmitter systems. Neuropharmacology 24: 965–968
Czuczwar SJ, Turski L, Schwarz M, Turski WA, Kleinrok Z (1984) Effects of excitatory amino-acid antagonists on the anticonvulsant action of phenobarbital or diphenylhy-dantoin in mice. Eur J Pharmacol 100: 357–362
DeNoble VJ, Jones KW, Schaeffer CL, Bauerle LM (1990) 3-[(±)-2-Carboxypiperazin-4-yl]propyl-1-phosphonic acid (CPP) and phencyclidine produce a deficit of passive avoidance retention in rats. Eur J Pharmacol 175: 197–202
Izquierdo I (1989) Mechanisms of action of scopolamine as amnestic. TIPS 10: 175–177
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113
MacDonald JF, Barlett MC, Mody I, Pahapill P, Reynolds JN, Salter MW, Schneiderman JH, Pennefather PS (1991) Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol (London) 432: 483–508
Olney JW, Price MT, Labruyere J, Salles S, Friederick G, Mueller M, Silverman E (1987) Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur J Pharmacol 142: 319–320
Parada-Turska J, Turski WA (1990) Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 29: 1111–1116
Pietrasiewicz T, Czechowska G, Dziki M, Turski WA, Kleinrok Z, Czuczwar SJ (1993) Competitive NMDA receptor antagonists enhance the antelectroshock activity of various antiepileptics. Eur J Pharmacol 250: 1–7
Pontecorvo MJ, Karbon EW, Goode S, Clissold DB, Borosky SA, Patch RJ, Ferkany JW (1991) Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Res Bull 26: 461–465
Ransom RW (1991) Polyamine and ifenprodil interactions with the NMDA receptor's glycine site. Eur J Pharmacol-Mol Pharmacol Sect 208: 67–71
Reynolds IJ, Miller RJ (1989) Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Mol Pharmacol 36: 758–765
Rogawski MA (1992) The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs 44: 279–292
Singh L, Oles RJ, Vass CA, Woodruff GN (1991) A slow intravenous infusion of N-methyl-D, L-aspartate as a seizure model in the mouse. J Neurosci Methods 37: 227–232
Swinyard EA, Brown WC, Goodman LS (1952) Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106: 319–330
Troupin AS, Mendius JR, Cheng F, Risinger MW (1986) MK-801. In: Meldrum BS, Porter RJ (eds) New anticonvulsant drugs. Demos Publications, London, pp 191–201
Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA (1989) Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3: 154–171
Turski WA, Czuczwar SJ, Kleinrok Z, Turski L (1983) Cholinomimetics produce seizures and brain damage in rats. Experientia 39: 1408–1411
Urbańska E, Dziki M, Czuczwar SJ, Kleinrok Z, Turski WA (1992) Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshok-induced seizures. Neuropharmacology 31: 1021–1026
Urbańska E, Dziki M, Kleinrok Z, Czuczwar SJ, Turski WA (1991) Influence of MK-801 on the anticonvulsant activity of antiepileptics. Eur J Pharmacol 200: 277–282
Venault P, Chapouthier G, De Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986) Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task. Nature 321: 864–866
Wasterlain CG, Jonec V (1981) Cholinergic kindling of the amygdala requires the activation of muscarinic receptors. Exp Neurol 73: 595–599
Williams K, Romano C, Dichter MA, Molinoff PB (1991) Modulation of the NMDA receptor by polyamines. Life Sci 48: 469–498
Wong EHF, Kemp JA, Pristley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci 83: 7104–7108
Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ (1993) 2, 3-Dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice. Neuropharmacology 32: 895–900
Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ (1994) The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice. Neuropharmacology (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zarnowski, T., Kleinrok, Z., Turski, W.A. et al. The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice. J. Neural Transmission 97, 1–12 (1994). https://doi.org/10.1007/BF01277958
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01277958